shark2007
The glory road
- Registrato
- 27/10/07
- Messaggi
- 55.992
- Punti reazioni
- 3.374
GSK - Titolo per investitori alla ricerca dell'elisir di lunga vita
GlaxoSmithKline reaches agreement with Aspen to divest thrombosis brands and related manufacturing site for £0.7 billion | 2013 | Press releases | Media | GlaxoSmithKline
Regulatory update ? GSK and Genmab announce European submission to regulatory authorities for Arzerra® (ofatumumab) as 1st line treatment of Chronic Lymphocytic Leukaemia (CLL) | 2013 | Press releases | Media | GlaxoSmithKline
Malaria vaccine candidate reduces disease over 18 months of follow-up in late-stage study of more than 15,000 infants and young children | 2013 | Press releases | Media | GlaxoSmithKline
GlaxoSmithKline reaches agreement with Aspen to divest thrombosis brands and related manufacturing site for £0.7 billion | 2013 | Press releases | Media | GlaxoSmithKline
Regulatory update ? GSK and Genmab announce European submission to regulatory authorities for Arzerra® (ofatumumab) as 1st line treatment of Chronic Lymphocytic Leukaemia (CLL) | 2013 | Press releases | Media | GlaxoSmithKline
Malaria vaccine candidate reduces disease over 18 months of follow-up in late-stage study of more than 15,000 infants and young children | 2013 | Press releases | Media | GlaxoSmithKline